Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Issue of Equity and Award of Options

31st Jan 2013 07:00

RNS Number : 7486W
Ideagen PLC
31 January 2013
 

Ideagen plc

("Ideagen" or the "Company")

Issue of Equity and Award of Options

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management announces an issue of equity to satisfy the deferred consideration payable in relation to the acquisition of Root3 Systems Limited ("Root3") in March 2010. Ideagen also announces a further issue of equity following the exercise of options by an employee and the award of options to certain Directors and other employees of the Company . 

 

The Company will issue 304,880 Ordinary Shares as deferred consideration for the acquisition of Root3 as detailed in the announcement regarding the acquisition of Root3 on 12 March 2010. The Company will also issue 200,000 Ordinary Shares to an employee following the exercise of options. Application has been made to the London Stock Exchange for 504,880 Ordinary Shares to be admitted to trading on AIM, admission is expected to take place at 8.00 a.m. on 5 February 2013.

 

 

The Company has granted incentive stock options to certain directors and employees of the Company. The stock options were granted over a total of 4,500,000 common shares, representing approximately 3.7% of the issued share capital of the Company at an exercise price of 22.38p per share, being the closing price of Ideagen's shares on 29 January 2013. 4,295,000 of the stock options have been awarded pursuant to the Company's existing EMI scheme and are exercisable in equal tranches over the next three years. The balance of 205,000 options granted to Graeme Spenceley was not been granted pursuant to the Company's existing EMI scheme. However these options have all of the same terms as the EMI options save that they cannot be registered with HM Revenue and Customs and therefore will not have the same tax benefits.

 

The allocation of stock options to directors was as follows:

 

Director

Position

New Options

Total Options following the grant of New Options

Current Shareholding in Ideagen

Percentage of current issued share capital

David Hornsby

Chief Executive Officer

500,000

4,633,333

8,284,833

6.8

Les Paul

Chief Technical Officer

1,000,000

1,000,000

7,268,640

6.0

Graeme Spenceley

Finance Director

1,000,000

2,000,000

Nil

Nil

 

 

Following admission of, in aggregate 504,880 Ordinary Shares to trading on AIM on 10 January 2013, the total voting rights in the Company will be 121,740,656. This figure should be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.

 

 

 

Ideagen Plc

 

 

Tel: 01629 761590

David Hornsby, Chief Executive

 

www.ideagenplc.com

Graeme Spenceley, Finance Director

 

 

 

 

finnCap Limited

 

Tel: 020 7220 0500

Matt Goode/Ben Thompson (corporate finance)

 

Stephen Norcross (corporate broking)

 

 

Walbrook PR Ltd

 

Tel: 020 7933 8780

Helen Westaway

 

[email protected]

Paul Cornelius

 

[email protected]

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGFMRGKGFZM

Related Shares:

IDEA.L
FTSE 100 Latest
Value8,275.66
Change0.00